Adoptive transfer of tumor infiltrating lymphocytes for metastatic cervical cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Adoptive transfer of tumor infiltrating lymphocytes for metastatic cervical cancer ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Creator
-
Hinrichs, Christian S.
- Contributor
-
Stevanović, Sanja
Draper, Lindsey
Langhan, Michelle
Dudley, Mark
Wunderlich, John
Rosenberg, Steven A.
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P15
- URN
-
urn:nbn:de:1111-2016072650875
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hinrichs, Christian S.
- Stevanović, Sanja
- Draper, Lindsey
- Langhan, Michelle
- Dudley, Mark
- Wunderlich, John
- Rosenberg, Steven A.
- SpringerLink (Online service)
Other Objects (12)
S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2
Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy
Tumor-Infiltrating Lymphocytes in Wilms Tumor
T cell receptor repertoire characteristics and therapeutic potential of tumor infiltrating lymphocytes (TILs) derived from metastatic lymph node in cervical cancer
Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer
Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy
S47. Tumour infiltrating lymphocytes - a predictive marker?
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2
Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy
Tumor-Infiltrating Lymphocytes in Wilms Tumor
T cell receptor repertoire characteristics and therapeutic potential of tumor infiltrating lymphocytes (TILs) derived from metastatic lymph node in cervical cancer
Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer
Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy
S47. Tumour infiltrating lymphocytes - a predictive marker?
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2
Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy
Tumor-Infiltrating Lymphocytes in Wilms Tumor
T cell receptor repertoire characteristics and therapeutic potential of tumor infiltrating lymphocytes (TILs) derived from metastatic lymph node in cervical cancer
Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer
Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy
S47. Tumour infiltrating lymphocytes - a predictive marker?